Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Tectonic Therapeutic, Inc. (TECX) Market Cap & Valuation Ratios

Tectonic Therapeutic, Inc. (TECX) has a market cap of $392.4M, with earnings according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

TECXTectonic Therapeutic, Inc.Follow TECX — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
392.4M
P/E TTM
—
Dividend yield
0.0%
52-week
—
Next earnings
5 Nov, in 12 days

Peers

biotechnology · nearest by market cap · trailing 12 months
CompanyMkt cap, $BP/EEV/SalesEV/EBITDAFCF yieldRev. growthOp. marginROIC
TECX0.4———————
ALLO0.4—21.4————-52%
PRTA0.4—2.4—-14.4%+427%-102%—
ALT0.4————+105%—-22%
AUTL0.4—1.8——+292%-211%—
SPRY0.4—3.0——+4%-185%-214%
CCCC0.4—8.5——+2%-319%-84%
AVTX0.4————-87%—-43%
MPLT0.4——————-88%
EDIT0.4—4.5——+21%-161%—
FENC0.4—5.3——+78%-2%-94%
Median of these 10—4.5—-14.4%+49%-173%-84%

.

Growth vs. price

each dot a company · hover or tap for values

Tectonic Therapeutic, Inc. — questions

What is Tectonic Therapeutic, Inc.'s market cap?
$392.4M.

Every figure on this page comes from Tectonic Therapeutic, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.